|
|
Post by racedog on Dec 8, 2017 11:13:06 GMT -5
I thought I would post this here because I think MNKD has this very thing happening to them and Deerfield seems to be big in these things in the past. Go to MiMedx website and click on the link that reads: Letter to MiMedx Shareholders Corrected MiMedx |
|
|
|
Post by cretin11 on Dec 8, 2017 11:44:27 GMT -5
Interesting strategy. Based on MDXG's share price, it appears to have been at least somewhat effective so far?
|
|
|
|
Post by dreamboatcruise on Dec 8, 2017 12:52:23 GMT -5
I thought I would post this here because I think MNKD has this very thing happening to them and Deerfield seems to be big in these things in the past. Go to MiMedx website and click on the link that reads: Letter to MiMedx Shareholders Corrected MiMedxw It seems MiMedx (assuming their rebuttals are the truthful side of the story) had shorts really putting out false information. With MNKD even those (that I know of) that write hit pieces have done so by merely by pointing at sales of Afrezza and speculating that it will be a flop. It's much harder for a company to write a rebuttal to that if the underlying statements about past sales are correct... other than perhaps to issue forward looking guidance, but then you need to be sure to actually achieve it or you've just lost credibility for the company and given it to the shorts. |
|
|
|
Post by me on Dec 8, 2017 13:02:14 GMT -5
I thought I would post this here because I think MNKD has this very thing happening to them and Deerfield seems to be big in these things in the past. Go to MiMedx website and click on the link that reads: Letter to MiMedx Shareholders Corrected MiMedxw It seems MiMedx (assuming their rebuttals are the truthful side of the story) had shorts really putting out false information. With MNKD even those (that I know of) that write hit pieces have done so by merely by pointing at sales of Afrezza and speculating that it will be a flop. It's much harder for a company to write a rebuttal to that if the underlying statements about past sales are correct... other than perhaps to issue forward looking guidance, but then you need to be sure to actually achieve it or you've just lost credibility for the company and given it to the shorts. If you read some of their other documents, you'll see that MiMedx very clearly states it's not false information that has such a negative effect on their share price, but rather the manipulation of shares via the coordination of negative press (false, only misleading, or otherwise) and naked short selling. With MNKD, I have seen a frequent pattern of negative innuendo in the press that is eerily contemporaneous with downward pressure via short selling (some would say naked short selling). It's the coordination of the two that MiMedx is fighting and it's these circumstances that seem familiar to many on this board with regard to MNKD. |
|
|
|
Post by dreamboatcruise on Dec 8, 2017 13:22:28 GMT -5
me ... perhaps SEC should tighten the rule on fail to delivers (delays in delivery), but setting that aside because in the end shares are delivered, it makes sense that those wishing to drive the price down and profit from shorting would do the bashing and shorting in a coordinated manner the same way those wishing to drive the price up and profit from buying would would coordinate positive spin with buying... or in the recent case of MNKD coordinate the positive spin with doing a PIPE. Nothing illegal about being savvy with driving one's trade... as long as one isn't fraudulent in the negative or positive info being pushed. I'm just pointing out that MNKD has little if anything to rebut. They can complain about the level of shorting, but shorting isn't going to go away in general, and it won't diminish for MNKD until they show a path to profitability and those remove the overhang of further large amounts of dilution.
|
|
|
|
Post by mnkdfann on Dec 8, 2017 13:41:00 GMT -5
Interesting strategy. Based on MDXG's share price, it appears to have been at least somewhat effective so far? Look at the five year chart. The price doesn't look all that out of whack with the long term trend. Even now (trading around $11.6), it has a PEG (PEG, not PE) ratio near 2.4. That's not cheap. Maybe it is a fantastic company, but it is easy to argue it was way overvalued some months ago when it was trading over $16. I haven't read the short attack articles. They may well be using fraudulent 'facts', but their underlying claim the company was / is overvalued may well have merit. |
|
|
|
Post by sportsrancho on Dec 8, 2017 17:03:14 GMT -5
This goes on daily.... he posts after every article. He lies about how Afrezza works. He says the reps are not qualified. That Vdex is a hoax, and mankind is a scam. That the claims about Afrezza and how good it is are false. That the people are paid.. Rising SKEPTIC, "But my point today, is that shareholders need to recognize that a company can't be only a dream..."  But MY point is that the company is NEITHER a "dream" NOR even a "company," but ONLY a SCAM whose purpose is ONLY to provide management with FAT salaries, benefits, bonuses, and perks. |
|
|
|
Post by me on Dec 8, 2017 17:52:13 GMT -5
This goes on daily.... he posts after every article. He lies about how Afrezza works. He says the reps are not qualified. That Vdex is a hoax, and mankind is a scam. That the claims about Afrezza and how good it is are false. That the people are paid.. Rising SKEPTIC, "But my point today, is that shareholders need to recognize that a company can't be only a dream..." But MY point is that the company is NEITHER a "dream" NOR even a "company," but ONLY a SCAM whose purpose is ONLY to provide management with FAT salaries, benefits, bonuses, and perks. That's because he's a bitter, ex-employee who got canned. |
|
|
|
Post by mnkdlonginbrla on Dec 8, 2017 17:59:13 GMT -5
For additional information listen to MiMedx most recent investor
Conference call. Follow Marc Cohodes on Twitter.
This company is being brutally attacked and the similarities
to Mannkind is striking.
The big difference with MiMedx and Mannkind is CEO Pete Petit is aggressively going after these crooks.
This story reads like a good novel.
|
|
|
|
Post by longliner on Jan 17, 2023 22:29:36 GMT -5
video.foxbusiness.com/v/6318820035112/According to our resident experts this is a myth. I look forward to seeing where Mannkind fits into the story. As he says, the best thing a company can do to is become profitable.....
|
|
|
|
Post by cretin11 on Jan 18, 2023 8:26:58 GMT -5
This thread is a nice walk down memory lane. Back then many (most?) of us here believed MNKD was being somehow “held down” by crooked shorts or some version of that. We created an echo chamber of sorts, where we kept reinforcing that narrative and automatically doubting anyone whose opinion differed.
Turns out the poster dreamboatcruise was better tuned in than the rest of us, his/her posts ring true with hindsight, for example “I'm just pointing out that MNKD has little if anything to rebut. They can complain about the level of shorting, but shorting isn't going to go away in general, and it won't diminish for MNKD until they show a path to profitability and those remove the overhang of further large amounts of dilution.”
Six year later, still true and finally we are close. Better late than never!
|
|
